15 oct
|
Hemab Therapeutics
|
Badajoz
15 oct
Hemab Therapeutics
Badajoz
Hemab Therapeutics seeks an experienced Medical Science Liaison for Europe to serve as the scientific link to clinicians, investigators and the bleeding-disorder community across European markets. With sutacimig advancing toward Phase 3 in Glanzmann Thrombasthenia and other programs, your field insights will guide study design and evidence generation.
You will build trusted relationships, enable site activation, and collaborate with Clinical Development, Clinical Operations and Medical Affairs
J-*-Ljbffr
📌 European Medical Science Liaison (Badajoz)
🏢 Hemab Therapeutics
📍 Badajoz